Product Recommendations NGAL- Early Marker of Acute Kidney Injury

What is NGAL? The full name of NGAL is human lipocalin 2 (Ln2) or siderocalin. It belongs to the lipocalin family and is the earliest proposed marker of acute kidney injury (AKI).   What is the clinical significance of NGAL? 1. NGAL is a marker of acute kidney injury (AKI) When AKI occurs

PDF) Early Diagnosis of Acute Kidney Injury: The Promise of Novel Biomarkers

NGAL - Bioporto

Acute Kidney Injury

Frontiers Predictive value of neutrophil gelatinase-associated lipocalin in children with acute kidney injury: A systematic review and meta-analysis

Emerging early diagnostic methods for acute kidney injury

Advances in Clinical and Experimental Medicine

Biomedicines, Free Full-Text

Biomarkers for acute kidney injury: is NGAL ready for clinical use?

Meta‑analysis of the diagnostic value of serum, plasma and urine neutrophil gelatinase‑associated lipocalin for the detection of acute kidney injury in patients with sepsis

Novel Biomarkers Detecting early-stage Acute Kidney Injury (AKI)

Figure 1 from Neutrophil gelatinase-associated lipocalin (NGAL) as biomarker of acute kidney injury: a review of the laboratory characteristics and clinical evidences

Proteomic identification of early urinary-biomarkers of acute kidney injury in preterm infants

Neutrophil Gelatinase-assoc Lipocalin (NGAL): promising biomarker of acute kidney injury - Advanced ImmunoChemical Inc.Advanced ImmunoChemical Inc.